Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Convalescent Plasma in Ugandan Adults
NCT04542941Completed
- Sponsor
- Makerere University
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Makerere University. Primary endpoint: Time to viral clearance (RT-PCR negativity) at 28 days. Started Jun 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04542941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542941.